IN RE ENOVIX CORPORATION SECURITIES LITIGATION

District Court, N.D. California·Decided July 25, 2025·No. 3:23-cv-00071·Unknown

Opinion

1 2 3 6 7 IN RE: ENOVIX CORP. SECURITIES Case No. 23-cv-00071-SI

ORDER RE: DISCOVERY DISPUTE 9 Re: Dkt. Nos. 163, 164, 166, 169, 171, 173 10 11

12 13 The parties have filed a discovery dispute regarding the extent to which plaintiffs should 14 produce documents responsive to defendants’ Requests for Production Nos. 3, 4, and 6. Dkt. Nos. 15 164, 166. 16 18 In this securities fraud action, defendants seek certain documents related to the former 19 employee (“FE”) witnesses on whom plaintiffs relied in their Second Amended Complaint. 20 Defendants represent that “[f]ive confidential witnesses on whom Plaintiffs relied in their Second 21 Amended Complaint (‘SAC’) have submitted sworn declarations disavowing the exact 22 allegations—that equipment repeatedly failed the ‘FAT’ [factory acceptance] testing in China— 23 upon which this Court relied in allowing the SAC to survive Defendants’ motion to dismiss.” Dkt. 24 No. 164 at 1. In response, plaintiffs argue that the declarations defendants obtained “do not 25 contradict the complaint in any material way,” that their own investigators’ declarations contradict 26 what defendants represent, and that the information defendants seek is protected attorney work 27 product. Dkt. No. 166 at 1 & n.2. Plaintiffs also accuse defendants of proceeding in bad faith in 1 deadline.” Id. at 2. 2 Upon receipt of the parties’ separate discovery dispute letters, the Court ordered defendants 3 to file the sworn declarations from the five confidential witnesses and ordered plaintiffs to file the 4 declarations from their investigators. Dkt. No. 167. The parties have since filed the declarations, 5 Dkt. Nos. 168, 170, along with “gratuitous” letters accusing the other side of submitting unsolicited 6 argument in their communications with the Court, Dkt. Nos. 172, 174.1 7 To summarize the status of the requests, defendants seek: unredacted interview memoranda 8 of plaintiffs’ investigators (including drafts); instructions to plaintiffs’ investigators regarding 9 interviews; policies and procedures relating to plaintiffs’ investigators’ interviews; communications 10 with plaintiffs’ investigators, including notes memorializing the same; and engagement letters for 11 plaintiffs’ investigators. Dkt. No. 164 at 2. According to defendants, plaintiffs produced five 12 investigator memos and two declarations but have otherwise refused on work product grounds. 13 Additionally, defendants state that information regarding Former Employee 2 was produced in 14 heavily redacted form. Id. Plaintiffs state that they have offered: (1) all communications between 15 (a) the parties/counsel/investigators and (b) any of the FEs cited in the complaint; (2) expedited 16 depositions of the ‘disavowing’ FEs; and (3) limited waiver of work product protection to show the 17 investigators’ memos (or relevant portions thereof) memorializing the statements made by the 18 ‘disavowing’ FEs (which are the only investigation materials Plaintiffs used to draft the FE 19 allegations in the complaint).” Dkt. No. 166 at 2. Plaintiffs also state that their production of the 20 first category of documents is contingent upon defendants’ reciprocity, but that defendants have 21 refused, asserting Upjohn privilege. Id. at 2 n.4. 22 24 Federal Rule of Civil Procedure 26 lays out the general scope of discovery:

25 Unless otherwise limited by court order, the scope of discovery is as follows: Parties may obtain discovery regarding any nonprivileged 26

27 1 The Court finds good cause to maintain the names of the confidential witnesses under seal matter that is relevant to any party’s claim or defense and proportional 1 to the needs of the case, considering the importance of the issues at stake in the action, the amount in controversy, the parties’ relative 2 access to relevant information, the parties’ resources, the importance of the discovery in resolving the issues, and whether the burden or 3 expense of the proposed discovery outweighs its likely benefit. 4 Fed. R. Civ. P. 26(b)(1). The work product doctrine is codified in Federal Rule of Civil Procedure 5 26(b)(3), which provides, in relevant part:

6 (A) Documents and Tangible Things. Ordinarily, a party may not discover documents and tangible things that are prepared in 7 anticipation of litigation or for trial by or for another party or its representative (including the other party’s attorney, consultant, 8 surety, indemnitor, insurer, or agent). But, subject to Rule 26(b)(4), those materials may be discovered if: 9 (i) they are otherwise discoverable under Rule 26(b)(1); and 10 (ii) the party shows that it has substantial need for the 11 materials to prepare its case and cannot, without undue hardship, obtain their substantial equivalent by other means. 12 (B) Protection Against Disclosure. If the court orders discovery of 13 those materials, it must protect against disclosure of the mental impressions, conclusions, opinions, or legal theories of a party’s 14 attorney or other representative concerning the litigation. . . . 15 Fed. R. Civ. P. 26(b)(3). 16 18 At the outset, the Court agrees with plaintiffs that certain of the requests for production are 19 overbroad, in particular Nos. 4 and 6. These requests seek, inter alia, “All DOCUMENTS 20 CONCERNING any COMMUNICATIONS between YOU and/or LEAD COUNSEL on the one 21 hand, and any former or current employee or consultant of or PERSON acting on behalf of ENOVIX 22 . . . about ENOVIX . . .” and “All DOCUMENTS CONCERNING any INVESTIGATION, whether 23 formal or informal, conducted by YOU . . . CONCERNING any allegation in the COMPLAINT . . 24 . .” Dkt. No. 164, Ex. A at RFP Nos. 4 and 6. And while defendants have raised some troubling 25 allegations, particularly regarding whether the FEs understood that their interviews might be 26 included in a securities fraud complaint, it is also true that plaintiffs have already handed over their 27 investigator memoranda from the FE interviews, which is more than what some judges have ordered 1 WL 798600, at *2 (N.D. Cal. Mar. 11, 2025) (ordering plaintiffs to produce “verbatim quotes from 2 the confidential witness only and no other portion” of confidential witness memoranda). Further, 3 defendants are aware of the identities of the FEs and may depose them. Indeed, plaintiffs have 4 offered depositions on an expedited basis. In light of what plaintiffs have offered, there is no need 5 for widespread disclosure of communications with any former employees or regarding anything to 6 do with plaintiffs’ investigation. 7 At this time, the Court finds plaintiffs’ offer regarding production appropriately balances the 8 need for disclosure with the concerns regarding attorney work product. Plaintiffs shall respond to 9 the discovery requests with: “(1) all communications between (a) the parties/counsel/investigators 10 and (b) any of the FEs cited in the complaint; (2) expedited depositions of the ‘disavowing’ FEs; 11 and (3) limited waiver of work product protection to show the investigators’ memos (or relevant 12 portions thereof) memorializing the statements made by the ‘disavowing’ FEs . . . .” See Dkt. No. 13 166 at 2. The Court will not order plaintiffs to respond with documents regarding any former 14 employee who is not cited in the operative complaint. See Weston v. Docusign, Inc., No. 22-cv- 15 00824-WHO, 2024 WL 3446924, at *2 (N.D. Cal. July 15, 2024).

Free access — add to your briefcase to read the full text and ask questions with AI

IN RE ENOVIX CORPORATION SECURITIES LITIGATION, (N.D. Cal. 2025).

IN RE ENOVIX CORPORATION SECURITIES LITIGATION (IN RE ENOVIX CORPORATION SECURITIES LITIGATION) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related